Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS. Wood H Nat Rev Neurol. 2013 May; 9(5):238. Epub 2013 Apr 16. PMID: 23588353. Abstract CommentRecommendBookmarkWatch